AI assistant
PTC THERAPEUTICS, INC. — Director's Dealing 2020
Jan 9, 2020
31046_dirs_2020-01-08_127d2082-4fe3-4b90-95e7-dfc45bf8cfe9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2020-01-06
Reporting Person: Hill Emily Luisa (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-01-06 | Common Stock | S | 121 | $48.168 | Disposed | 7484 | Direct |
| 2020-01-06 | Common Stock | S | 200 | $48.168 | Disposed | 7284 | Direct |
| 2020-01-07 | Common Stock | S | 63 | $49.621 | Disposed | 7221 | Direct |
Footnotes
F1: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 382 RSUs from a January 3, 2017 grant of 1,530 RSUs.
F2: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 600 RSUs from a January 3, 2018 grant of 2,400 RSUs.
F3: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 179 RSUs from a January 4, 2016 grant of 715 RSUs.